Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / CL A
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
29,980,270
-
Shares change
-
+1,908,004
-
Total reported value, excl. options
-
$1,138,926,248
-
Value change
-
+$111,838,910
-
Put/Call ratio
-
138%
-
Number of buys
-
90
-
Number of sells
-
-64
-
Price
-
$37.99
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2022
213 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q4 2022.
REATA PHARMACEUTICALS INC - CL A (RETA) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,980,270 shares
.
Largest 10 shareholders include CPMG Inc (2,896,901 shares), VANGUARD GROUP INC (2,705,656 shares), BlackRock Inc. (2,501,958 shares), First Light Asset Management, LLC (2,062,453 shares), FRED ALGER MANAGEMENT, LLC (1,509,404 shares), WELLINGTON MANAGEMENT GROUP LLP (1,507,882 shares), DEUTSCHE BANK AG\ (1,492,238 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,305,853 shares), Boxer Capital, LLC (1,230,004 shares), and Sofinnova Investments, Inc. (992,029 shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.